353 related articles for article (PubMed ID: 11146725)
1. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
2. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
Wilson MW; Rodriguez-Galindo C; Billups C; Haik BG; Laningham F; Patay Z
Ophthalmology; 2009 Aug; 116(8):1558-63. PubMed ID: 19545904
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.
Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972
[TBL] [Abstract][Full Text] [Related]
6. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
7. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma.
De Jong MC; van der Meer FJ; Göricke SL; Brisse HJ; Galluzzi P; Maeder P; Sirin S; De Francesco S; Sastre-Garau X; Metz KA; Cerase A; Noij DP; van der Valk P; Moll AC; Castelijns JA; de Graaf P;
Radiology; 2016 Jun; 279(3):817-26. PubMed ID: 26690907
[TBL] [Abstract][Full Text] [Related]
10. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G
Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
[TBL] [Abstract][Full Text] [Related]
13. Outcome of children with retinoblastoma and isolated choroidal invasion.
Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
Khelfaoui F; Validire P; Auperin A; Quintana E; Michon J; Pacquement H; Desjardins L; Asselain B; Schlienger P; Vielh P
Cancer; 1996 Mar; 77(6):1206-13. PubMed ID: 8635145
[TBL] [Abstract][Full Text] [Related]
15. Postenucleation adjuvant therapy in high-risk retinoblastoma.
Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
[TBL] [Abstract][Full Text] [Related]
16. Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.
Chawla B; Sharma S; Sen S; Azad R; Bajaj MS; Kashyap S; Pushker N; Ghose S
Ophthalmology; 2012 Apr; 119(4):850-6. PubMed ID: 22218144
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic observation of 465 patients with retinoblastoma with optic nerve invasion].
Wang Y; Huang D; Shi J; Ma J; Zhao J; Li B; Xu X; Hu H; Zhou Y
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):109-13. PubMed ID: 25876685
[TBL] [Abstract][Full Text] [Related]
18. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
19. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
